Bisphosphonate safety and efficacy in chronic kidney disease

Slides:

Advertisements

Similar presentations

Navdeep Tangri, Paul V.J. Komenda, Claudio Rigatto

Advertisements

Melamine toxicity: one more culprit in calcium kidney lithiasis

Volume 73, Issue 1, Pages 3-5 (January 2008)

Propofol-related green urine

Anemia management in chronic kidney disease

Dylan Burger, Adeera Levin Kidney International

Volume 83, Issue 3, Pages (March 2013)

Stem cells for kidney repair: useful tool for acute renal failure?

ESA and iron therapy in chronic kidney disease: a balance between patient safety and hemoglobin target Szu-Chun Hung, Der-Cherng Tarng Kidney International

Shining light on vitamin D trials in chronic kidney disease

Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007 Joanna M. Smith, Susan A. Mott,

Reassessment of the care of the patient with chronic kidney disease

Volume 80, Issue 10, Pages (November 2011)

John P. Middleton, Patrick H. Pun Kidney International

M. Fukagawa, S. Nakanishi, J.J. Kazama Kidney International

Volume 58, Issue 1, Pages (July 2000)

Volume 85, Issue 3, Pages (March 2014)

Jeffrey C. Fink, Glenn M. Chertow Kidney International

Volume 73, Issue 9, Pages (May 2008)

Bioavailable vitamin D in chronic kidney disease

Volume 72, Issue 6, Pages (September 2007)

Comorbidity and confounding in end-stage renal disease

Volume 74, Issue 3, Pages (August 2008)

Volume 70, Issue 11, Pages (December 2006)

Volume 73, Issue 4, Pages (February 2008)

Volume 79, Pages S20-S23 (April 2011)

Volume 86, Issue 2, Pages (August 2014)

Use of vitamin D in chronic kidney disease patients

Volume 87, Issue 2, Pages (February 2015)

Junichiro J. Kazama, Masafumi Fukagawa Kidney International

Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.

Volume 83, Issue 5, Pages (May 2013)

Volume 88, Issue 4, Pages (October 2015)

The Case ∣ Best not shaken or stirred

Melamine toxicity: one more culprit in calcium kidney lithiasis

Volume 73, Issue 12, Pages (June 2008)

Navdeep Tangri, Paul V.J. Komenda, Claudio Rigatto

Extracorporeal therapy in sepsis: are we there yet?

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Tilman B. Drüeke, Ziad A. Massy Kidney International

Volume 74, Issue 8, Pages (October 2008)

Volume 87, Issue 3, Pages (March 2015)

Methods for guideline development

Old friends form alliance against podocytes

Volume 56, Issue 4, Pages (October 1999)

The global challenge of chronic kidney disease

Nephrology Crossword: Glomerulonephritis

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Volume 75, Issue 9, Pages (May 2009)

Will there be an epidemic of HIV-related chronic kidney disease in sub-Saharan Africa? Too soon to tell Kara K. Wools-Kaloustian, Samir K. Gupta Kidney.

Volume 82, Issue 7, Pages (October 2012)

Vitamin D in chronic kidney disease: is the jury in?

Cardio-Kidney-Damage: a unifying concept

Nanocrystals seed calcification in more ways than one

The emerging role of phosphate in vascular calcification

The vascular secret of Klotho

Pablo A. Ureña Torres, Marc De Broe Kidney International

Volume 80, Issue 10, Pages (November 2011)

Volume 83, Issue 4, Pages (April 2013)

Tobias Breidthardt, Alexandre Mebazaa, Christian E. Mueller

Volume 75, Issue 7, Pages (April 2009)

Cell biological and physicochemical aspects of arterial calcification

Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge? Ellen G. Neven, Marc E. De Broe, Patrick.

Volume 74, Issue 10, Pages (November 2008)

Volume 75, Issue 8, Pages (April 2009)

Breast arterial calcification in chronic kidney disease: absence of smooth muscle apoptosis and osteogenic transdifferentiation W. Charles O'Neill, Amy.

The Ebf1 knockout mouse and glomerular maturation

Sugar-sweetened beverages and chronic disease

Ronen Levi, Justin Silver Kidney International

Presentation transcript:

Bisphosphonate safety and efficacy in chronic kidney disease Susan M. Ott Kidney International Volume 82, Issue 8, Pages 833-835 (October 2012) DOI: 10.1038/ki.2012.253 Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 1 Interactions between low bone turnover and vascular calcifications in chronic kidney disease. Vascular smooth muscle cells differentiate into osteoblasts under the influence of vitamin D and Wnt signaling. The osteoblasts secrete frizzled-related protein (sFRP), which blocks the Wnt signaling but also causes low bone formation. Bisphosphonates could exacerbate this. The low bone formation leads to increased serum phosphate, which stimulates the changes in the smooth muscle cells. Kidney International 2012 82, 833-835DOI: (10.1038/ki.2012.253) Copyright © 2012 International Society of Nephrology Terms and Conditions